BridgeBio Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Jul 23 | Sell€46,730,250 | Viking Global Investors LP | Company | 1,500,000 | €31.15 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
General Public | 4,262,289 | 2.28% |
Individual Insiders | 9,737,697 | 5.2% |
Hedge Funds | 25,120,991 | 13.4% |
VC/PE Firms | 31,060,971 | 16.6% |
Institutions | 116,947,312 | 62.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
31,060,971 | €738.1m | 0% | 5.8% | |||
25,120,991 | €597.0m | 0% | 2.5% | |||
13,222,126 | €314.2m | 3.3% | 0.01% | |||
10,466,935 | €248.7m | 3.05% | no data | |||
6,905,851 | €164.1m | 0.44% | no data | |||
6,068,125 | €144.2m | 0% | 66.03% | |||
5,392,862 | €128.2m | 6.01% | 0.01% | |||
5,176,328 | €123.0m | -1.25% | 3.92% | |||
3,415,604 | €81.2m | 25.3% | 4.04% | |||
3,312,706 | €78.7m | 190% | 0.03% | |||
3,203,029 | €76.1m | -4.22% | 4.45% | |||
2,932,429 | €69.7m | 5.97% | 0.05% | |||
2,862,845 | €68.0m | 5.48% | 0.01% | |||
2,844,299 | €67.6m | 11.2% | 0.02% | |||
2,804,394 | €66.6m | -9.48% | 0.22% | |||
2,325,535 | €55.3m | -3.67% | no data | |||
2,249,073 | €53.4m | 7.42% | 0.01% | |||
2,212,085 | €52.6m | 101% | no data | |||
1,860,364 | €44.2m | 0% | 0.23% | |||
1,790,070 | €42.5m | 15% | 0.04% | |||
1,741,441 | €41.4m | 5.82% | 0.01% | |||
1,541,885 | €36.6m | 3.13% | 0.01% | |||
1,412,033 | €33.6m | -19.3% | 0.77% | |||
1,396,419 | €33.2m | 26.3% | 0.13% | |||
1,367,489 | €32.5m | -1.71% | 0.29% |